Renalytix (Reg S) (RENX)

Sector:

Health Care

Index:

FTSE AIM All-Share

27.17p
   
  • Change Today:
    -0.33p
  • 52 Week High: 145.00
  • 52 Week Low: 10.25
  • Currency: UK Pounds
  • Shares Issued: 126.22m
  • Volume: 0
  • Market Cap: £34.29m
  • RiskGrade: 348

RENX Overview

RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI’s solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1244.6% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 12.7 n/a
Pr/Book 2.3  
Latest F'cast
Revenue 14.6% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

RENX Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-19 n/a (7.12) (17.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-20 n/a (10.61) (16.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-21 1.49 (35.79) (43.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-22 2.97 (49.63) (78.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-23 3.40 (46.22) (56.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

RENX Company Announcements

Form 8.5 (EPT/RI) - Renalytix plc 24-Apr-2024 07:38 GlobeNewswire NA
Form 8.5 (EPT/RI) - Renalytix plc 23-Apr-2024 12:00 RNS
Issue of Shares and Rule 2.9 Announcement 22-Apr-2024 17:27 RNS

RENX ShareCast News

Renalytix surges on takeover approach 04-Mar-2024 ShareCast
Renalytix shares jump on draft US Medicare cover... 09-Feb-2024 ShareCast
Renalytix kidney test claims allowed by US Paten... 06-Oct-2023 ShareCast

Latest RENX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

RENX Market Data

Currency UK Pounds
Share Price 27.17p
Change Today -0.33p
% Change -1.21 %
52 Week High 145.00
52 Week Low 10.25
Volume 0
Shares Issued 126.22m
Market Cap £34.29m
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
18.23% below the market average18.23% below the market average18.23% below the market average18.23% below the market average18.23% below the market average
3.23% above the sector average3.23% above the sector average3.23% above the sector average3.23% above the sector average3.23% above the sector average
Price Trend
91.74% below the market average91.74% below the market average91.74% below the market average91.74% below the market average91.74% below the market average
67.57% below the sector average67.57% below the sector average67.57% below the sector average67.57% below the sector average67.57% below the sector average
Income Not Available
Growth
18.52% above the market average18.52% above the market average18.52% above the market average18.52% above the market average18.52% above the market average
27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average

RENX Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page